Lei Xu

Dr. Lei Xu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

6 May 2025 in Veterinary Research
Verified
Journal Article
Open access
PDF file
LDLinlin Ding
Linlin Ding
KQKaige Qi
Kaige Qi
YZYutong Zhou
Yutong Zhou
QLQingjie Li
Qingjie Li
MLMinda Liu
Minda Liu
LXLei Xu
Lei Xu
Pullorum disease, caused by Salmonella pullorum (S. pullorum), is a highly contagious illness affecting the poultry industry. Emerging evidence suggests that Artemisia argyit essential oil can influence the composition of gut microbes in the host, thereby promoting overall health. However, the specific mechanisms by which Artemisia argyit essential oil modulates gut microbiota to combat S. pullorum infection remains unclear. This study explored the effectiveness of various doses of Artemisia argyit essential oil in preventing S. pullorum infection in chicks. Our findings indicate that consuming this essential oil can mitigate the intestinal mucosal barrier damage and excessive inflammatory response caused by S. pullorum, as well as reverse the weight loss seen in infected chicks. Additionally, chicks that received faecal microbiota transplantation (FMT) from the gut microbiota of Artemisia argyit essential oil donors exhibited notable recovery from S. pullorum infections. This suggests that the observed protection may be linked to the modulation of gut microbiota. Furthermore, 16S rRNA sequencing revealed an increased abundance of Lactobacillus reuteri (L. reuteri), which along with the activation of Wnt/β-catenin pathways, played critical roles in the enhanced health of S. pullorum-infected chicks treated with Artemisia argyit essential oil. In summary, these findings highlight that the dietary inclusion of Artemisia argyit essential oil promotes the intestinal enrichment of L. reuteri, offering a promising strategy for the treatment and prevention of pullorum disease in chicks.

30 September 2025 in Phytomedicine
Verified
Journal Article
Closed access
LDLinlin Ding
Linlin Ding
QLQingjie Li
Qingjie Li
KQKaige Qi
Kaige Qi
YCYonghui Chen
Yonghui Chen
NHNa Hu
Na Hu
LXLei Xu
Lei Xu

28 March 2025 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MLMinda Liu
Minda Liu
TFTianqi Fang
Tianqi Fang
SWShanshan Wang
Shanshan Wang
HMHongxia Ma
Hongxia Ma
LKLingcong Kong
Lingcong Kong
LXLei Xu
Lei Xu

23 June 2025 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
SHSangyu Hu
Sangyu Hu
WZWeigang Zhong
Weigang Zhong
YPYuzhu Pei
Yuzhu Pei
YZYutong Zhou
Yutong Zhou
JWJianfeng Wang
Jianfeng Wang
LXLei Xu
Lei Xu
The emergence of drug-resistant bacterial infection and persistent biofilm colonization pose a rigorous challenge to effective wound healing and regeneration, necessitating the innovative therapeutic strategies to combat these pressing clinical crises. Herein, nortriptyline, a novel United States Food and Drug Administration (FDA)-approved tricyclic antidepressant was uncovered to effectively potentiate bactericidal activities of β-lactam antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). Mechanistically, nortriptyline functions by disrupting the microbial iron homeostasis and potentiation of Fenton chemistry-mediated oxidative stress, concomitant with metabolic reprogramming via tricarboxylic acid (TCA) cycle dysregulation and membrane destabilization. To enhance combination therapy-mediated therapeutic potential in wound management, the dual-loaded self-healing hydrogel OHA-PLL@AN was engineered to exhibit excellent biocompatibility and antibacterial potentials through molecular cross-linking of oxidized hyaluronic acid (OHA) and ε-polylysine (PPL). The therapeutic efficacy of OHA-PLL@AN was further validated in a murine model with MRSA-infected cutaneous wounds. OHA-PLL@AN therapy significantly attenuated the inflammatory response, concurrently promoting angiogenesis and accelerating the cutaneous wounds healing. Collectively, these findings underscore the dual drug-loaded self-healing hydrogel OHA-PLL@AN with anti-infection and anti-inflammatory properties as a novel therapeutic strategy for drug-resistant bacterial infected wounds therapy.

13 December 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
HWHeng Wang
Heng Wang
XHXinyue He
Xinyue He
LWLanqiao Wang
Lanqiao Wang
NWNan Wang
Nan Wang
XNXiaodi Niu
Xiaodi Niu
JWJianfeng Wang
Jianfeng Wang
Host-directed antibacterial compounds remain underdeveloped for intracellular pathogens. Here, we identify Dehydroevodiamine (DEHD) as a broad-spectrum host-directed antibiotics that inhibits intracellular bacterial replication (Salmonella, E. coli, S. aureus, etc.) and synergizes with antibiotics in vitro and in vivo. Structural analyses reveal DEHD directly binds MDM2 (KD=68.34 μM), activating the MDM2-P53-V-ATPases axis to maintain lysosomal acidity through V-ATPase activity and induce mTOR-dependent autophagy. This mechanism enhances antibiotic efficacy against resistant pathogens, reducing mortality from 90% to 10% in lethal murine infections. Our work establishes lysosomal activation via the MDM2-P53-V-ATPases axis as a potent host-directed strategy, with DEHD providing a promising lead compound against intracellular infections.